Wikiwand AI

N-Propyltryptamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

N-Propyltryptamine (NPT) is a serotonin receptor modulator of the tryptamine family related to N-methyltryptamine (NMT).[1][2][3] According to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), NPT is not known to have been tested in humans.[1] It acts as a serotonin receptor agonist in the rat uterus and stomach strip, with slightly lower potency than dimethyltryptamine (DMT).[4][3] However, in contrast to DMT and NMT, NPT did not cause central effects in dogs.[2][5] It is said to be less toxic than dipropyltryptamine (DPT) in rodents.[1] The chemical synthesis of NPT has been described.[1][6] NPT was first described in the scientific literature by Speeter and Anthony by 1954.[2][4][3][5] Subsequently, the drug was described by Shulgin in TiHKAL in 1997.[1]

Other namesNPT; N-n-Propyltryptamine
ATC code
  • None
Quick facts Clinical data, Other names ...
N-Propyltryptamine
Clinical data
Other namesNPT; N-n-Propyltryptamine
Drug classSerotonin receptor modulator
ATC code
  • None
Identifiers
  • N-[2-(1H-indol-3-yl)ethyl]propan-1-amine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC13H18N2
Molar mass202.301 g·mol−1
3D model (JSmol)
  • CCCNCCC1=CNC2=CC=CC=C21
  • InChI=1S/C13H18N2/c1-2-8-14-9-7-11-10-15-13-6-4-3-5-12(11)13/h3-6,10,14-15H,2,7-9H2,1H3
  • Key:KBFBIAGUZWNRFI-UHFFFAOYSA-N
Close

See also

References

Related Articles

Timelines

Top Qs

Fact Checks